首页|丹红注射液联合氨茶碱治疗慢性肺心病伴呼吸衰竭患者的效果

丹红注射液联合氨茶碱治疗慢性肺心病伴呼吸衰竭患者的效果

扫码查看
目的:观察丹红注射液联合氨茶碱治疗慢性肺源性心脏病(肺心病)伴呼吸衰竭患者的效果.方法:选取 2019 年 1 月至2023 年 1 月该院收治的 92 例慢性肺心病伴呼吸衰竭患者进行前瞻性研究,依据随机数字表法将其分为研究组和对照组各 46 例.两组均给予常规治疗,在此基础上,对照组行氨茶碱治疗,研究组在对照组基础上联合丹红注射液治疗,比较两组治疗前后血气指标[动脉血氧分压(PaO2)、血氧饱和度(SpO2)]水平、心肺功能指标[左心室收缩末期内径(LVESD)、左心室射血分数(LVEF)、用力呼出 50%肺活量的呼气流速(PEF50%)、肺总量(TLC)]水平、钠尿肽(BNP)水平、同型半胱氨酸(Hcy)水平和生命质量[健康调查简表(SF-36)]评分.结果:治疗后,研究组PaO2、SpO2 水平均高于对照组,差异有统计学意义(P<0.05);治疗后,研究组LVESD、TLC水平均低于对照组,LVEF、PEF50%水平均高于对照组,差异有统计学意义(P<0.05);治疗后,研究组BNP、Hcy水平均低于对照组,差异有统计学意义(P<0.05);治疗后,研究组精神健康、精力、社会功能、生理职能等SF-36评分均高于对照组,差异有统计学意义(P<0.05).结论:丹红注射液联合氨茶碱治疗慢性肺心病伴呼吸衰竭患者可提高血气指标水平和生命质量评分,改善心肺功能指标水平,降低BNP和Hcy水平,效果优于单纯氨茶碱治疗.
Effects of Danhong injection combined with Aminophylline in treatment of patients with chronic pulmonary heart disease complicated with respiratory failure
Objective:To observe effects of Danhong injection combined with Aminophylline in treatment of chronic pulmonary heart disease(cor pulmonale)with respiratory failure.Methods:A prospective study was conducted on 92 patients with chronic cor pulmonale and respiratory failure admitted to the hospital from January 2019 to January 2023.According to the random number table method,they were divided into study group and control group,46 cases in each group.Both groups were given routine treatment.On this basis,the control group was treated with Aminophylline,while the study group was treated with Danhong injection on the basis of that of the control group.The blood gas indexes[arterial oxygen partial pressure(PaO2),blood oxygen saturation(SpO2)]levels,the cardiopulmonary function indexes[left ventricular end systolic diameter(LVESD),left ventricular ejection fraction(LVEF),forced expiratory flow rate in 50%vital capacity(PEF50%),total lung capacity(TLC)]levels,the natriuretic peptide(BNP)level,the homocysteine(Hcy)level,and the quality of life[36-item health survey(SF-36)]score were compared between the two groups before and after the treatment.Results:After the treatment,the levels of PaO2 and SpO2 in the study group were higher than those in the control group,and the differences were statistically significant(P<0.05).After the treatment,the levels of LVESD and TLC in the study group were lower than those in the control group,the levels of LVEF and PEF50%were higher than those in the control group,and the differences were statistically significant(P<0.05).After the treatment,the levels of BNP and Hcy in the study group were lower than those in the control group,and the differences were statistically significant(P<0.05).Further,after the treatment,the SF-36 scores of mental health,vitality,social function and physiological function in the study group were higher than those in the control group,and the differences were statistically significant(P<0.05).Conclusions:Danhong injection combined with Aminophylline in the treatment of the patients with chronic cor pulmonale and respiratory failure can improve the levels of blood gas indexes and the quality of life scores,improve the levels of cardiopulmonary function indexes,and reduce the levels of BNP and Hcy.Moreover,it is superior to single Aminophylline treatment.

Chronic pulmonary heart diseaseRespiratory failureDanhong injectionAminophyllineCardiopulmonary functionQuality of lifeBlood gas index

李珂、李华

展开 >

安阳市中医院重症医学科,河南 安阳 455000

慢性肺源性心脏病 呼吸衰竭 丹红注射液 氨茶碱 心肺功能 生命质量 血气指标

2024

中国民康医学
中国社会工作协会

中国民康医学

影响因子:0.649
ISSN:1672-0369
年,卷(期):2024.36(6)
  • 15